top of page
Search

EmoLED Mini-Series Online

  • Writer: Kerr Biotech
    Kerr Biotech
  • Jul 21, 2021
  • 1 min read

Updated: May 4, 2024

Earlier this month the Emoled team based in Italy announced a free 4-part webinar mini-series featuring clinicians from Europe and Asia sharing their clinical experience with the EmoLED device and how blue-light photobiomodulation has impacted their own patients with chronic wounds.

"The overwhelming interest we received from local wound management clinicians confirms that there is a growing appetite to explore new modalities in wound management as the prevalence of non-healing wounds in Australia worsens. The imminent publication of EmoLEDs BLUR trial is going to push blue-light therapy into the market ahead of schedule"


The science of phototherapies is already well accepted in dermatology, now clinical experience in non-healing wounds is opening up a new frontier for patients in need.

Contact us to access a recording of the webinar or for more information on future events

The Event Overview

  • The event was opened by Dr Stefano Gasperini, the medical director of Emoled SRL. Dr Gasperini provided a succinct overview of Photobiomodulation with Blue LED Light in wound care therapy, explaining its mode of action and the origins of the EmoLED device.

  • Dr Marino Ciliberti presented results from the BLUR clinical study (Blue Light for Ulcer Reduction), showing evidence of the contribution of Blue Light to the healing of hard-to-heal wounds focusing predominantly in venous leg ulcers (VLU)

  • A/Prof Tjun Yip Tung shared his experience of EmoLED treatment of VLU ulcers based in Singapore reporting encouraging observations such as reductions in exudate

  • Dr Carla Pezzuto discussed the use of EmoLED for managing pressure ulcers, sharing the results of her preliminary experience in patients with spinal cord lesions.




 
 
 

Comments


bottom of page